Zdrowie i gospodarka · 13/01/2009

FDA Requests Comments on Increasing Participation of Underrepresented Populations in Clinical Drug Trials

The Food and Drug Administration (FDA) is seeking input from various stakeholders on how to improve the representation of elderly populations, children, and underrepresented communities in clinical drug trials, in line with the Food and Drug Administration Amendments Act of 2007 (FDAAA) requirements.